Pronutrir - suporte nutricional e quimioterapia ltda.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Hoffmann-La Roche2 trials

Running trials

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

  NCT05296798· Phase 3· Hoffmann-La Roche· Source

• Active, not recruiting

  A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

  NCT04576455· Phase 2· Hoffmann-La Roche· Source